Home > About Fogarty > Advisory Board > Report of the Director Archives > 05-22-2001
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Public Health Service
National Institutes of Health
John E. Fogarty International Center
for Advanced Study in the Health Sciences
Minutes of the Advisory Board
Forty-eighth Meeting
Table of Contents
- DHHS, NIH, and FIC Personnel Announcements
- FIC Budget
- FIC Programs and Initiatives
- FIC In-House Science Seminars
- Regional Activities
- Activities of FIC Staff Members
I. DHHS, NIH, and FIC Personnel Announcements
Claude A. Allen has been nominated by President George W. Bush to serve as Deputy Secretary of the Department of Health and Human Services. Mr. Allen served as the Secretary of Health and Human Resources for the State of Virginia and served in the Virginia Attorney General's Office from 1995-1998. He is a graduate of the University of North Carolina and Duke University Law School.
Paul A. Sieving, M.D., Ph.D. has been named Director of the National Eye Institute (NEI). Dr. Sieving comes to NIH from the Kellogg Eye Center at the University of Michigan, where he was Director of the Center for Retinal and Macular Degeneration at the Department of Ophthalmology and Visual Sciences, and the Paul R. Lichter Professor of Ophthalmic Genetics. He replaces Dr. Carl Kupfer, the first director of the NEI, who retired in July 2000.
Donna Dean, Ph.D. has been appointed by Dr. Ruth Kirschstein as Acting Director of the new NIH Institute for Biomedical Imaging and Bioengineering. Dr. Dean has served as Senior Advisor in the NIH Director's Office for the past three years. Previously, she was Director of the Division of Physiological Systems in the Center for Scientific Review (CSR) and Acting Chief of the Referral and Review Branch in CSR's predecessor, the Division of Research Grants.
II. FIC Budget
NIH FY 2002 Budget Request: The President's FY 2002 budget request for the NIH is $23.042 billion, an increase of $2.744 billion or 13.5 percent over the FY 2001 level of $20.298 billion. Within this level, the budget request for the AIDS program is $2.501 billion, an increase of $258.0 million or 11.5 percent over the FY 2001 of $2.243 billion. The budget request includes $40.2 million for the new National Institute of Biomedical Imaging and Bioengineering and $158.425 million for the National Center on Minority Health and Health Disparities.
FIC FY 2002 Budget Request: The FY 2002 budget request for the FIC is $56.449 million, an increase of $5.967 million or 11.8 percent over the FY 2001 level of $50.482 million. Within this level, the non-AIDS budget is $38.353 million, an increase of $ 4.023 million or 11.7 percent. The AIDS budget is $18.096 million, an increase of $1.944 million or 12.0 percent. The increase in the non-AIDS budget will permit expansion of the Fogarty International Research Collaboration Awards (FIRCA) Program and the establishment of the following three new research initiatives:
International Tobacco and Health Research and Capacity Building Program - This program will be the FIC response to the growing pandemic of tobacco-related illness and death caused by the use of tobacco products.
Stigma Research Initiative - This program will support the study of the causes of and response to stigmatization of public health problems in both the United States and abroad.
Incorporating New Genetic Tools in Global Public Health Strategies - This initiative will concentrate on the capacity to ethically incorporate new genetic technologies into global health research and introduce genetic research into planning for the future.
The
FY 2002 Congressional Justification can be found on the FIC website.
Budget Hearings: The Director, FIC, with the Directors of the National Institute of Allergy and Infectious Diseases, the National Human Genome Research Institute, the National Center for Minority Health and Health Disparities and the Office of Research on Women's Health, participated in the Special Populations/Health Disparities Theme Hearing before the House Appropriations Subcommittee on April 4. Dr. Keusch's opening statement can be found on the FIC website.
Dr. Kirschstein, Acting Director, NIH will testify on behalf of the FY 2002 President's budget before the House Appropriations Subcommittee on May 16 and before the Senate Appropriations Subcommittee on May 23. Dr. Kirschstein will be accompanied by NIH Institute/Center Directors. Each of the directors will submit a written statement to the Subcommittee.
Back to top ^
III. FIC Programs and Initiatives
Consultation with NIH Visiting Fellows from the Developing World
Together with NIH's Office of Intramural Research and Office of Research on Women's Health, FIC organized an informal consultation on March 26 to discuss ways in which the NIH experience can be enhanced to assist Visiting Fellows from the developing world make the transition when they return to their home countries. This includes training in the skills necessary to compete successfully for NIH research grants and to assume scientific leadership positions in their home countries. The consultation also addressed possible ways to increase the number of qualified scientists from the developing world who participate in the NIH Visiting Program.
International Tobacco and Health Research and Capacity Building Program
FIC, in cooperation with NCI, NICHD, NIDA, NIMH, and NINR, is preparing a comprehensive Request for Applications (RFA) that targets the needs of the developing world and the research interests of the NIH related to tobacco control. FIC has received input from scientific experts in the area of tobacco use and control and in the capacity strengthening needs of developing countries in these areas. The Center has also secured WHO sponsorship for this initiative. The RFA will target 5 key research areas including epidemiological and surveillance research, susceptibility and risk, biobehavioral and social research, intervention research and policy-related research. Grantees will be required to include a significant capacity and infrastructure-strengthening component in their programs. FIC anticipates that the RFA will appear in the NIH Guide to Grants and Contracts within the next few weeks.
Stigma Research Initiative
FIC and partners across NIH will host a conference September 5-7 that will focus on stigma and its impact in advancing medical research, access to health care, participation in clinical trials and other topics of concern in this country and in the developing world. FIC conceptualized this conference and is leading its organization in consultation with a trans-NIH committee. The burden of stigma due to disease will worsen significantly as the incidence of such marginalizing illnesses as HIV/AIDS and major depression increase. Individuals with stigmatized diseases are less likely to seek medical attention, causing higher morbidity and mortality among these "silently sick" populations. In order to address some of these crucial issues, FIC plans to issue a multi-IC RFA for stigma research for funding in FY 02.
Multilateral Initiative on Malaria (MIM)
The Annual Meeting of the MIM/TDR principal investigators of the 23 MIM African research and training grants was held in Harare, Zimbabwe in March. To strengthen the capability of African researchers to communicate their research and to encourage collaborations, the MIM Secretariat, housed at FIC, organized a two-day workshop for participants in writing scientific papers and making scientific presentations. The Secretariat also is working to address research gaps and is encouraging support for vector biology and control research and training. Towards this end, the Secretariat held a workshop at the Zimbabwe meeting to form recommendations for research on insecticide resistance. In addition, the MIM is fostering a new focus on international collaboration and funding of malaria caused by P. vivax and is currently organizing a conference on that topic to be held in Thailand in January, 2002. Finally, the MIM Secretariat is organizing the Third MIM Pan-African Conference, which will be held in Arusha, Tanzania in November 2002. The preliminary program and logistical information can be found at: HTTP://mim.nih.gov/english/events/3rd_mim_conf/index.html
Genetics Initiative
FIC organized and chaired a workshop entitled "Addressing the Global Divide in Genetic Science: A Consultation with Scientists to Assess the Needs for Research and Training Programs in the Developing World." The workshop was held May 16 in Vienna, Austria as part of the International Congress of Human Genetics. Discussions at the workshop identified gaps in research and training needs in this area. Input from this consultation is instrumental as the Center works to develop an initiative that is relevant for both developing country researchers and counterparts at the NIH and other science funding agencies.
International Clinical and Operational Research and Training Award (ICORTA)
FIC, in collaboration with NIMH, NIA, NIDCR, NCCAM and NIDA, issued an RFA in February for a program to develop multidisciplinary international training and research programs in clinical and operational research. Twenty-five applications were received for the April 27 deadline. The program emphasizes mental health, aging, complementary and alternative medicine, and drug abuse in the first issue of the RFA. The long-term goals of the program are to build global clinical, operational and health services research capacity and collaborations in an effort to better understand, investigate, control, prevent, treat, and manage a range of global health problems. Awards are intended to strengthen global capacity to design and conduct clinical, operational and health services research necessary to characterize disease burdens, to devise and evaluate practical and affordable therapeutic or preventive interventions, and to help developing nations contribute to and benefit from international efforts to apply new discoveries to clinical and public health practice. FIC expects to issue a similar RFA for FY 2002 funding focused on HIV/AIDS and tuberculosis.
International Bioethics Education and Career Development Award
Bioethics Listserv: FIC has created a listserv of FIC and NIH staff, grantees and trainees under the International Bioethics and Career Development Award, and other academics with an interest in international bioethics. The listserv provides a convenient forum for those who are interested in communicating on these issues.
RFA on International Bioethics Education and Career Development
FIC plans to revise and reissue the RFA for the International Bioethics Education and Career Development Award in June with a submission deadline of early 2002. The Center will organize a grant writing workshop for developing country participants who attend the next Global Forum on Bioethics in The Gambia in November, 2001.
International Research Scientist Development Awards (IRSDA)
The mechanism for application to the IRSDA has been changed from an RFA to a Program Announcement with a regular deadline of February 13 of each year. Eleven applications, which were received for the February 2001 deadline, will be reviewed by NIAID.
Network Meetings
FIC recently convened a series of network meeting that enable grantees, trainees, and collaborating colleagues to exchange information on current projects. Network meetings were held under the International Training and Research Program in Population and Health; International Bioethics and Career Development Award; International Maternal and Child Health Research and Training Program; and International Training and Research Program in Emerging Infectious Diseases, including the Actions for Building Capacity Awards Program linked to the NIAID ICIDR Program.
Back to top ^
IV. FIC In-House Science Seminars
March 6 - "The Role of Modeling in Infectious Disease Epidemiology: Cases of Mixed Infections" - Dr. Ellis McKenzie, Harvard University
March 16 - "The Ethical Conduct of Genetic Research in Populations: Do We Need New Principles?" - Dr. Bartha Knoppers, University of Montreal
March 20 - "The Relationship Between Entomologic Inoculation Rates of Anopheles and Malaria Morbidity" - Ms. Meklit Berhan Hailemeskal (FIC intern, Stanford University)
April 5 - "International Tobacco and Health Capacity Building Program" - Dr. Joel Breman and Ms. Anne Hill, FIC
April 6 - "The Science and Planning of the Global Biodiversity Information Facility" - Dr. James Edwards, National Science Foundation
April 25 - "Overview of the Activities of the Medicines for Malaria Venture (MMV)." a public/private partnership for the discovery and development of new antimalarial drugs - Robert G. Ridley, Christopher Hentschel and P.V. Venugopal, MMV.
May 3 - "Equivalent Protection: Advancing U.S. Policy on International Research Ethics" - Dr. James Lavery, FIC
May 16 - "Links between NIH and the biomedical research community in Korea" - Dr. Yong Ae Shin, NIH
V. Regional Activities
U.S. Civilian Research and Development Foundation (CRDF)
In February, the CRDF announced a new competition for its Cooperative Grants Program, with proposals due May 18. This program allows joint teams of U.S. and former Soviet Union (FSU) scientists and engineers to apply for one-to two-year support for cooperation in any area of civilian research and development in the natural sciences, mathematics, engineering, and biomedical and behavioral sciences. The average award size is $40,000 per year, with at least 80% of the funds supporting project-related expenses of the FSU team. Thus far, five NIH institutes have pledged to contribute approximately $700,000 towards funding projects in the biomedical and behavioral sciences, specifically encouraging proposals in the fields of alcohol research, bioengineering, medical rehabilitation research and development of prosthetic devices.
Egypt
FIC, the National Cancer Institute and Mansoura University in Egypt organized a workshop on "The Sustainable Use of Biodiversity in Egypt" April 3-5 in Mansoura, Egypt. The workshop, held under the auspices of the Joint Science and Technology Board of the U.S.-Egypt Partnership for Economic Growth and Development, included presentations by researchers from the U.S., Canada, and Egypt. Egyptian participation included representatives from the university of Mansoura, Suez Canal, Alexandria, South Valley, and The Mubarak City for Science and Technology
The First Lady of Egypt, Mrs. Suzanne Mubarak, visited NIH on April 2. Her visit stemmed from an interest in women's and children's health issues, two topics she has championed in Egypt for the past two decades, and in U.S.-Egypt scientific cooperation. She met with Drs. Kirschstein, Maddox, Pinn and Hrynkow, as well as two Egyptian scientists currently working at NCI.
Italy/Africa
FIC, in cooperation with the National Research Council of Italy (CNR), organized an International Workshop on African Biodiversity, which took place in Rome, Italy April 9-11. The purpose of the workshop was to gather scientists, experts, industrial partners and policy makers from Italy, Africa, and the United States to share information on the current, state-of-the-art science of discovery and utilization of plant and marine biodiversity in Africa for the production of new drugs or products for agricultural use. Participants included 17 representatives of 12 African nations, 36 Italian researchers and administrators, and 11 representatives of the U.S. Government and academia. Another aim of the workshop was to lay the foundation for developing a Natural Product Research Network involving Italy, the United States (including International Cooperative Biodiversity Groups supported by NIH, NSF and USDA) and African laboratories and Centers of Excellence. Outcomes included a commitment to facilitate and expand research and training for the exploration and utilization of African biodiversity. CNR agreed to serve as Secretariat and to establish a website for the nascent network, while FIC will develop a listserv. In addition, CNR announced its intention to develop a targeted program and call for proposals based on the concepts and recommendations that emerged from the working groups and general discussions.
Chile
FIC, in conjunction with the Institute of Biomedical Sciences at the University of Chile, NIEHS and NCI, organized an NIH-Chile Research Cooperation Workshop in Environmental Health April 3-6 in Santiago. The workshop resulted in development of collaborative research proposals in four areas: signal transduction, genomics and bioinformatics, environmental toxicology, and cancer.
Argentina and Chile
Argentina and Chile, through their Ministry of Health and Commission for Science and Technology, respectively, have agreed to participate in the NIH Pan American Fellowship Program, which currently includes Mexico, Colombia and Uruguay. Argentina and Chile will begin to nominate Fellows to work in NIH intramural laboratories beginning in the Fall of 2001. In addition, the Argentinean Ministry of Health has agreed to provide re-entry grants to Argentinean Fellows in the amount of $30,000, renewable for up to three years, to cover stipend and research expenses when they return home.
Vietnam
The Vietnamese Government has ratified a bilateral U.S.-Vietnam Science and Technology (S&T) agreement, which was signed by U.S. Ambassador Douglas Peterson in November 2000. As required under the agreement, a Vietnamese delegation led by Dr. Chu Hao, Vice Minister of Science, Technology and Environment will visit Washington May 19-23 for what is expected to be the first meeting of the Joint U.S.-Vietnam S&T Committee. Dr. Norman Neuriter, S&T Advisor to the Secretary of State, will serve as the U.S. co-chair for this meeting.
Back to top ^
VI. Activities of FIC Staff Members
Dr. Gerald Keusch gave a seminar February 13 at Princeton University on promoting research capacity and infrastructure as an instrument of public health policy in the developing world. The seminar was part of a course on Health Policy.
Dr. Keusch gave four lectures at the 27th Stanford University/Palo Alto Medical Foundation Winter Course in Infectious Diseases at Snowmass, Colorado, February 28-March 2.
Dr. Keusch joined a three member panel to address the topic of "Genomics and its Impact on Public Health" as part of a continuing series on the Future of Public Health March 15 at the Harvard School of Public Health.
Dr. Keusch gave a presentation on potential linkages between the MIM and the Hashimoto Initiative in Global Parasite Control at the Asian Centre of International Parasite Control (ACIPAC) International Symposium March 19-20 in Bangkok, Thailand. The presentation was entitled "Save Schoolchildren from Parasites."
Dr. Keusch made a presentation on the MIM to senior Korean Government officials as part of the MIM effort to expand activities in Asia and on P. vivax . He used the opportunity to visit the International Vaccine Institute (IVI) in Seoul and to hear progress on IVI activities.
Dr. Keusch attended a meeting at the Rockefeller Foundation April 6 in New York to make a presentation on intellectual property rights issues as related to global health and the public good.
Dr. Keusch attended the fourth meeting of the Commission on Macroeconomics and Health April 10-11 in Washington, D.C. Topics for discussion included "Nutrition, Health and Economic Development," Economic Aspects of Mental Health," and "HIV/AIDS in the Caribbean and Africa."
Dr. Keusch co-chaired a session on "Human Capacity and Training" at the AIDS Care in Africa Conference in Entebbe, Uganda, April 18-19. The conference was sponsored by the Rockefeller Foundation.
Dr. Keusch attended the American Society for Clinical Investigation/American Association of Physicians 2001 Joint Meeting April 27-29 in Chicago, Illinois. Participants discussed the mentoring of physician scientist trainees and recent advances in molecular genetics and cell biology, and highlighted the importance of transgenic and gene targeting technologies in new animal models of human disease.
Dr. Keusch and Dr. Norman Neuriter, Science Advisor to the Secretary of State, made a joint presentation on Technologies to Advance Global Health at the initial meeting of the Center for Strategic and International Studies Working Group on technologies for the future. The meeting was held May 3 in Washington.
Dr. Keusch attended the Federation of American Societies for Experimental Biology's Spring Policy Conference entitled "Government-Academic-Industrial Partnerships: Bioethics and Genome Research," May 6-7 in Bethesda, Maryland.
Dr. Keusch gave a presentation on the goals and mission of FIC at New York University's Institute for Global Health May 11 in New York.
Dr. Martin Alilio gave a presentation entitled "Malaria in Africa: Emerging Prevention and Control Challenges" at the Annual Meeting of the American Association for the Advancement of Science in San Francisco February 15-20.
Dr. Alilio gave two presentations at the 2001 Annual Meeting of the AAAS February 15-20 in San Francisco. The presentations were entitled " International Collaboration on Malaria Research, Control and Prevention," and Malaria: A Reemerging Disease."
Dr. Alilio gave a presentation entitled "Health Sector Reforms in Africa" to students in a Master's Program in International Health at the University of Copenhagen March 6.
Dr. Alilio attended the Annual Meeting of MIM/TDR Principal Investigators in Harare, Zimbabwe March 10-13. He organized the meeting of the Scientific Advisory Committee of the III Pan-African Conference on Malaria, which took place during the MIM/TDR Meeting.
Mr. Amar Bhat represented FIC/NIH in Brussels May 13-16 for meetings with the European Commission's Directorate-General for Research to discuss ongoing and potential areas of cooperation. He also represented FIC/NIH at the U.S.-EU Science and Technology Joint Consultative Group meeting on May 15.
Dr. Joel Breman's efforts in mentoring Ms. Stephanie Tuttle during her internship at FIC during the summer of 2000, contributed significantly to her thesis on "Malaria: Self Treatment and Effects on Household Costs." Ms. Tuttle's work has been nominated for the Dean's Prize at Yale University's School of Public Health.
Dr. Breman attended the Annual Meeting of MIM/TDR Principal Investigators March 8-18 in Harare, Zimbabwe. At that meeting, he co-chaired the meeting of the Scientific Program Committee for the MIM Pan-African Malaria Conference, that will be held in Arusha, Tanzania from November 18-22, 2002; attended the review of 23 MIM/TDR scientific projects presented by African scientists receiving MIM grants; and participated in a workshop on oral presentations and manuscript preparation supported by MIM.
Dr. Breman gave a seminar entitled "The Burden of Malaria" at the Harvard School of Public Health April 12 in Boston, Massachusetts.
Dr. Breman participated in the 4th Roll Back Malaria Meeting held at the World Bank on April 17-19, Washington, D.C.
Dr. Breman organized and chaired a review of the status of monkeypox surveillance and research attended by representatives of WHO, FIC, NIAID, CDC, USAMRIID and OIRH/DHHS. The recent reports of large numbers of cases of human monkeypox in Democratic Republic of the Congo has triggered concern in Africa and elsewhere that monkeypox may be becoming a public health problem. The review was held April 18 at NIH.
Dr. Breman was an invited speaker at the 50th Anniversary Celebration of the Epidemic Intelligence Service, at the Centers for Disease Control and Prevention in Atlanta, Georgia April 21-24. His talk was entitled "Just a few days...Ebola, Zaire, 1976".
Dr. Kenneth Bridbord gave a presentation entitled "Building Sustainable Research and Public Health Capacity through International Scientific Cooperation" at the Annual Meeting of the American Association for the Advancement of Science February 18 in San Francisco.
Dr. Bridbord and Dr. Jeanne McDermott attended a Research Consultation on The Care of HIV/AIDS Affected Mothers and Children in Africa in Gaborone, Botswana March 25-29. Dr. McDermott co-chaired a number of working group meetings at the NICHD-sponsored meeting.
Dr. Bridbord gave a presentation entitled "Building Research Capacity for HIV/AIDS Treatment and Care for Africa" at the AIDS Care in Africa Conference in Entebbe, Uganda April 18-19.
Dr. Andrea Egan attended the Annual Meeting of MIM/TDR Principal Investigators March 10-13 in Harare, Zimbabwe. At the meeting, she gave a presentation on the MIM, attended the meeting of the Scientific Advisory Committee for the III Pan-African Malaria Conference, and organized and ran a two-day Workshop on Writing and Presenting Science.
Dr. Egan gave a presentation on the MIM at the 4th Meeting of the Global Partnership to Roll Back Malaria April 18-19 at the World Bank in Washington, D.C.
Dr. Karen Hofman attended an advisory meeting convened by WHO to discuss priorities related to ethical, legal and social implications of genomics February 12-13 in Geneva.
Dr. Hofman represented NIH at a meeting to discuss the most recent version of the Declaration of Helsinki convened by the World Medical Association and the European Forum for Good Clinical Practice hosted by the University of Pretoria March 27-28 in Pretoria, South Africa.
Dr. Hofman gave a presentation and met with researchers in molecular biology and those who provide genetic services at the University of Witwatersrand School of Health Sciences in Johannesburg, South Africa on March 26 and with a similar group at the University of Pretoria School of Medicine and School of Public Health on March 28 to discuss needs for research and training programs related to genetics in South Africa.
Dr. Hofman, Dr. Barbara Sina, and Ms. Anne Hill organized and conducted a workshop at the International Congress of Human Genetics on May 16 in Vienna, Austria with approximately 100 scientists from the developing world. The session was entitled "Addressing the Global Divide in Genetic Science: A Consultation with Scientists to Assess the Needs for Research and Training Programs in the Developing World."
Dr. Allen Holt participated in a UNESCO Workshop on Ethical Issues Related to Biotechnology and Biosafety April 2-3 in Hangzhou, China. The meeting, organized by the Director of the Beijing Genomics Institute of the Chinese Academy of Sciences, initiated China's study of ethical, social and legal implications of human genetics research and the protection of human subjects.
Dr. Sharon Hrynkow represented NIH at a DHHS meeting with World Bank officials on March 13. Her presentation focused on current areas of joint activity with The World Bank and on potential future areas of cooperation.
Dr. Hrynkow gave a presentation entitled "Scary Viruses and Other Scourges: Global Health Challenges and Solutions" on April 16 at the Federal Executive Institute in Charlottesville, Virginia.
Dr. Hrynkow represented NIH at the 43rd meeting of the Standing Committee of the European Medical Research Councils April 27 in Strasbourg, France.
Dr. Hrynkow gave a presentation on "Career Opportunities at the Bench and Beyond" on May 3 to Ph.D. students and postdoctoral fellows at the University of Connecticut Health Center in Farmington, Connecticut.
Dr. Hrynkow represented NIH on the U.S. delegation to the 42nd Session of the Governing Council of the International Agency for Research on Cancer (IARC) May 10-11 in Lyon, France.
Dr. Hrynkow gave a presentation to the presidents of the Infectious Diseases Society of America's (IDSA) Board of State and Regional Societies on the activities of the Fogarty International Center. The meeting, held May 18-20 in Dallas, Texas, focused on ways to improve communications between IDSA and the regional and state societies.
Dr. Richard Krause was in India in February and March to finalize an agreement with the Department of Biotechnology (DBT) and Indian Council for MedicalResearch regarding a Vaccine Action Program grant on the epidemiology of streptococcal infections. The study, whose purpose is to determine the incidence of group A strep infections in school children ages 7-11 and to identify possible sites for future vaccine trials, will be conducted in a village near Chandigarh, India and in a village near Vellore in the South. Final approval for funding, in the amount of $200,000 in rupees, was given by the DBT for three years. Information on the incidence of streptococcal disease is needed to estimate the size of cohorts required to determine efficacy of a candidate vaccine. A vaccine is needed in developing countries to prevent the occurrence of rheumatic heart disease.
Dr. Krause attended the Environmental Cancer and Mutagenesis Panel of the United States-Japan Cooperative Medical Science Program meeting on Okinawa in February for the purpose of preparing a 5-year review of the work of the U.S. and Japan Panels.
Dr. James Lavery gave a lecture on International Research Ethics at the American Academy for the Advancement of Science short-course on Research Ethics in Washington, D.C., March 18.
Dr. Lavery organized and chaired a symposium on ethical issues in research at a NICHD Consultation Meeting on Maternal and Child HIV/AIDS Treatment in Africa in Gaborone, Botswana, March 26.
Dr. Lavery gave a presentation on the implications of emerging guidelines in international research ethics for vaccine research as part of a three-member panel on research ethics at the National Foundation for Infectious Diseases conference on Vaccine Research in Alexandria, VA, April 23.
Dr. Lavery gave a presentation on Persistent Challenges in International Research Ethics as part of a four member panel at the NIH Staff Training for Extramural Programs (STEP) Forum: "Clinical Trials on Trial" in Bethesda, MD, May 17.
Dr. Lavery gave a presentation on Challenges in Training and Education in International Research Ethics, and facilitated a small-group workshop, at the Public Responsibility in Medicine & Research (PRIM&R) conference "Promoting the Responsible Conduct of Research: Policies, Challenges, and Opportunities" in Arlington, VA, May 18.
Dr. Jeanne McDermott attended the All India Meeting for AITRP programs convened by Johns Hopkins University March 5 in Baltimore.
Dr. McDermott attended the NICHD-sponsored consultation, "Exploring a Research Agenda to Improve the Care and Management of Mothers and Children Affected by HIV in Africa," in March 25-29 in Gaborone, Botswana.
Dr. McDermott participated in a seminar conducted by the HIV Center for Clinical and Behavioral Studies at Columbia University to discuss international and cross cultural perspectives in HIV/AIDS and sexuality research April 9-10 in New York City.
Dr. McDermott gave a presentation on "The Role of Midwives in Safe Motherhood: a Case Study from Indonesia" April 17 at Georgetown University.
Dr. McDermott gave a presentation on FIC training activities related to blood safety to a DHHS Advisory Committee on Blood Safety and Availability April 19 in Washington.
Dr. McDermott participated in a retreat convened by the Centers for AIDS Research of the NIH to discuss international initiatives. The meeting was held April 20 at the University of Pennsylvania in Philadelphia.
Dr. McDermott participated in a research workshop on neonatal survival interventions convened by WHO (Department of Child and Adolescent Health and Development) and Save the Children U.S. (Saving Newborn Lives Program) in Kathmandu Nepal, April 29-May 3, 2001.
Dr. Kathleen Michels gave a talk on international research opportunities to the NIH Postdoctoral Fellows Committee March 1 at NIH. This presentation was part of a broader FIC effort to increase awareness of U.S. and foreign post-doctoral fellows, and particularly those from the developing world, about NIH support and opportunities for international programs and activities.
Dr. Michels organized the international portion of the STEP Forum "Clinical Trials on Trial" May 17 at the NIH.
Dr. Mark Miller gave a talk on "Global Immunization Initiatives" to the National Vaccine Advisory Committee, February 14 in Washington, D.C.
Dr. Miller gave a presentation on "Vaccine Research, Availability...and Reality: Perspectives of International Health & Humanitarian Assistance Communities" at the US Medicine Institute for Health Studies sponsored by the Department of Defense, March 15 in Washington.
Dr. Miller participated in a WHO consultation on new measles vaccine candidates at Johns Hopkins School of Public Health, March 21.
Dr. Miller participated in the WHO Commission on Macroeconomics and Health Steering Committee/Working Group 5 Meeting March 27 in Lausanne, Switzerland.
Dr. Miller gave a talk on "Expanding Global Vaccine Coverage Financing, Health System Infrastructure and Economic Evaluation" at the Institute of Public Health, April 11 in Cuernavaca, Mexico.
Dr. Rachel Nugent attended the World Bank Annual Meetings on Development Economics on May 1-2, 2001 in Washington, DC. Health and development was one of the two major themes on which papers were presented.
Ms. Minerva Rojo participated in a workshop in Mobile, Alabama, March 25-27 hosted by the University of Alabama's Squirrel Monkey Breeding and Research Resource Center. The workshop brought together experts in squirrel monkey biology and field primatology from the U.S., Bolivia, and Argentina and focused on development of a field study to promote understanding of the Bolivian squirrel monkey and its potential use in the testing of future malarial drugs and vaccines. Ms. Rojo discussed the U.S. foreign policy issues relevant to both Argentina and Bolivia. The meeting concluded with a decision to conduct a field assessment of the population of squirrel monkeys in Bolivia over the next few months.
Dr. Luis Salicrup represented FIC at the III Inter-American Development Bank Consultative Group Meeting for Central America March 7-10, 2001 in Madrid, Spain. The meeting provided an opportunity for Central American governments to meet with multilateral organizations and international donors to discuss priority issues relevant to social and economic development in the region. Dr. Salicrup presented a paper on "Meeting the Challenges: Free Trade Workforce, Science and Technology Development in Central America" at a workshop on Human Development and Social Equity.
Dr. Salicrup represented FIC at a meeting of the PAHO Planning Committee for the regional symposium "Mental Health in the Americas: Partnering for Progress," which will take place November 5-6 in Washington.
Dr. Barbara Sina coordinated the MIM/TDR Symposium on Insecticide Resistance in Malaria Vectors at the MIM/TDR Meeting in Harare, Zimbabwe. A summary of the meeting has been accepted for publication in the next issue of "Trends in Parasitology." She also attended the MIM Task Force Meeting and the meeting of the Scientific Advisory Committee for the Pan-African Malaria Conference, which will be held in Arusha, Tanzania in November 2002.
Dr. Sina was an invited observer at the review of proposals to the Medicines for Malaria Venture (MMV) in Geneva March 14-16.
Dr. Sina gave a talk on "Mosquito Control and the Transmission of African Nile Virus" April 25 at the Sierra Club in Wheaton, Maryland.
Ms. Natalie Tomitch traveled to Berlin and Bonn, Germany April 2-6 for meetings with the Deutsche Forschungsgemeinschaft (NSF-equivalent), the Federal Ministry for Research and Education, the German-American Academic Council, and the Institute for Nutrition. The purpose of the meetings was to share information on current initiatives and to explore new potential opportunities for cooperation.
Ms. Tomitch and Dr. Joshua Rosenthal represented FIC in the International Workshop on African Biodiversity, which took place in Rome, Italy April 9-11.
Back to top ^
